The Leadership Team at QuellTX drives the strategic vision and operational execution of the company’s innovative Treg cell therapy initiatives. Comprising experts in medical, clinical, regulatory, and business domains, the team collaborates to steer research, oversee clinical development, ensure regulatory compliance, and foster a culture of excellence. Their collective expertise supports QuellTX's mission to advance groundbreaking therapies for solid organ transplants and autoimmune diseases.
Aaron Vernon
Chief Manufacturing Officer
Chris Sharpe
VP, Regulatory Affairs
Jodie Albutt
VP, IP
Luke Devey
Chief Medical Officer
Luke Henry, PhD
Chief Business Officer
Lyndsay Telakis FCIP...
Vice President, People & Cultu...
Marc Martinez-Llorde...
Co-founder & VP Biology
Nathalie Belmonte
SVP Research & Translation
Nathalie Clerget
VP clinical operations
Sue Bellamy
EA To Ceo, C-suite & Board Of ...
View all